Using ultrasound contrast to detect sentinel nodes in cancer
Part of Cancer, Skin clinical trials.
This trial tests whether contrast-enhanced ultrasound can help find sentinel lymph nodes (the first nodes cancer may spread to) in people with melanoma, breast, or head and neck cancer. It may reduce the need for a radioactive tracer injection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have melanoma, breast cancer, or a head and neck cancer (including melanoma in those areas).
- If you have melanoma, it must be on your limbs or head/neck area.
- You are scheduled for a sentinel node biopsy at The Netherlands Cancer Institute.
- You are not pregnant, and you have no severe allergies to eggs or egg products.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a magnetic tracer call Magtrace to help find and remove the first lymph node (sentinel node) during breast cancer surgery. The goal is to see if it works well for people having breast-conserving surgery.
This study uses special ultrasound imaging (and may use MRI results) to look for early signs of how locally advanced breast cancer responds to chemotherapy, with or without radiation. If the imaging changes early, it could help doctors adjust treatment sooner.
This trial tests an experimental drug that targets tumors with a special protein detected by a PET scan. It may help treat certain cancers like breast, head and neck, pancreatic, or brain cancers that have grown despite prior treatment.
This trial tests a new, detailed ultrasound technique that uses a contrast agent (called Definity) to get clearer images of a suspicious area before a biopsy. It may help doctors better see the blood flow in the lesion, which could improve diagnosis.
This trial uses contrast-enhanced ultrasound (a special type of ultrasound) to see how well neck lymph nodes respond to chemotherapy and immunotherapy given before surgery for head and neck squamous cell carcinoma.
This trial tests a contrast agent called Sonazoid, which is used during an ultrasound to get clearer pictures of the liver. It is for children and teens who have one or more spots in the liver that need to be checked. The goal is to see if Sonazoid is safe and works well for children.
Hear when a new Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.